Binding Site Information of Target
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T11283 | Target Info | |||
Target Name | Mitochondrial matrix protein P1 (HSPD1) | ||||
Synonyms | P60 lymphocyte protein; HuCHA60; Hsp60; Heat shock protein 60; HSP-60; Chaperonin 60; CPN60; 60 kDa heat shock protein, mitochondrial; 60 kDa chaperonin | ||||
Target Type | Clinical trial Target | ||||
Gene Name | HSPD1 | ||||
Biochemical Class | Chaperonin ATPase | ||||
UniProt ID |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
Ligand Name: adenosine diphosphate | Ligand Info | |||||
Structure Description | ADP-bound human mitochondrial Hsp60-Hsp10 football complex | PDB:6MRC | ||||
Method | Electron microscopy | Resolution | 3.08 Å | Mutation | No | [1] |
PDB Sequence |
GSAKDVKFGA
10 DARALMLQGV20 DLLADAVAVT30 MGPKGRTVII40 EQSWGSPKVT50 KDGVTVAKSI 60 DLKDKYKNIG70 AKLVQDVANN80 TNEEAGDGTT90 TATVLARSIA100 KEGFEKISKG 110 ANPVEIRRGV120 MLAVDAVIAE130 LKKQSKPVTT140 PEEIAQVATI150 SANGDKEIGN 160 IISDAMKKVG170 RKGVITVKDG180 KTLNDELEII190 EGMKFDRGYI200 SPYFINTSKG 210 QKCEFQDAYV220 LLSEKKISSI230 QSIVPALEIA240 NAHRKPLVII250 AEDVDGEALS 260 TLVLNRLKVG270 LQVVAVKAPG280 FGDNRKNQLK290 DMAIATGGAV300 FGEEGLTLNL 310 EDVQPHDLGK320 VGEVIVTKDD330 AMLLKGKGDK340 AQIEKRIQEI350 IEQLDVTTSE 360 YEKEKLNERL370 AKLSDGVAVL380 KVGGTSDVEV390 NEKKDRVTDA400 LNATRAAVEE 410 GIVLGGGCAL420 LRCIPALDSL430 TPANEDQKIG440 IEIIKRTLKI450 PAMTIAKNAG 460 VEGSLIVEKI470 MQSSSEVGYD480 AMAGDFVNMV490 EKGIIDPTKV500 VRTALLDAAG 510 VASLLTTAEV520 VVTEIPKE
|
|||||
|
THR30
4.018
MET31
2.480
GLY32
1.710
PRO33
2.717
LYS51
3.265
GLY53
4.660
ASP87
2.680
GLY88
2.460
THR89
3.128
THR90
2.429
THR91
3.555
ILE150
2.895
|
|||||
Click to View More Binding Site Information of This Target and Ligand Pair |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Structural basis for active single and double ring complexes in human mitochondrial Hsp60-Hsp10 chaperonin. Nat Commun. 2020 Apr 21;11(1):1916. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.